Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
crispr
5
×
detroit blog main
detroit top stories
eli lilly
5
×
life sciences
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
fda
glaxosmithkline
indiana blog main
indiana top stories
cancer
clinical trials
ipo
startups
abbvie
alzheimer's disease
baricitinib
cancer immunotherapy
congress
What
bio
roundup
new
companies
crispr
life
moves
science
week
approval
bails
big
biogen’s
biopharma
biopharmaceutical
black
bosley's
bosley’s
brand
bridge
bridgebio
bucks
capital
car
cas
ceo
congress
congressional
continue
convo
crime
debut
departure
develop
diamond
diamond’s
drug
drugs
earlier
editas
Language
unset
Current search:
crispr
×
" life sciences "
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More